ArticleInfectious diseases and therapy2022

Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens.

Taylor Morrisette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.